MedNation (EIF.F) Stock Price

MedNation Price

CLOSED
4.10EUR-0.02 (-0.49 %)
Market closed

Revenue has compounded at 1.5% per year over the past 19 years to 48.76 M EUR. Earnings per share have grown at 3.5% per year over the last 19 years. MedNation's net margin stands at 0.2%, up from -4.0% several years earlier. MedNation currently offers a dividend yield of about 10.00%. The dividend has grown at 15.9% per year over the past 12 years. The stock trades about 155% above its 52-week low.

MedNation stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of MedNation over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how MedNation stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing MedNation's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

MedNation Stock Price History
DateMedNation Price
8/7/20264.10 EUR
8/6/20264.12 EUR
8/5/20264.14 EUR
8/4/20264.30 EUR
7/31/20264.08 EUR
7/30/20264.12 EUR
7/29/20264.00 EUR
7/28/20264.20 EUR
7/27/20264.16 EUR
7/24/20264.10 EUR
7/23/20264.00 EUR
7/22/20264.16 EUR
7/21/20264.20 EUR
7/20/20264.20 EUR
7/17/20264.20 EUR
7/16/20264.20 EUR
7/15/20264.12 EUR
7/14/20264.18 EUR
7/13/20264.10 EUR
7/10/20264.20 EUR
7/9/20264.12 EUR
7/8/20264.10 EUR
7/7/20264.04 EUR
7/6/20264.20 EUR
7/3/20264.30 EUR
7/2/20264.04 EUR
7/1/20264.00 EUR
6/30/20263.90 EUR
6/29/20263.90 EUR
6/26/20263.90 EUR
6/25/20264.04 EUR
6/24/20264.00 EUR
6/23/20264.00 EUR
6/22/20264.00 EUR
6/19/20264.04 EUR
6/18/20264.04 EUR
6/17/20264.00 EUR
6/16/20264.04 EUR
6/15/20264.34 EUR
6/12/20264.04 EUR
6/11/20264.20 EUR
6/10/20264.20 EUR
6/9/20264.30 EUR
6/8/20263.64 EUR
6/5/20264.06 EUR
6/4/20264.06 EUR
6/3/20264.18 EUR
6/2/20264.18 EUR
6/1/20264.30 EUR
5/29/20264.20 EUR
5/28/20264.20 EUR
5/27/20264.14 EUR
5/26/20264.38 EUR
5/25/20263.80 EUR
5/22/20264.20 EUR
5/21/20263.90 EUR
5/20/20263.80 EUR
5/19/20263.80 EUR
5/18/20263.88 EUR
5/15/20263.70 EUR
5/14/20263.70 EUR
5/13/20263.70 EUR
5/12/20263.70 EUR
5/11/20263.70 EUR
5/8/20263.52 EUR
5/7/20263.58 EUR
5/6/20263.52 EUR
5/5/20263.52 EUR
5/4/20263.56 EUR
4/30/20263.50 EUR
4/29/20263.50 EUR
4/28/20263.42 EUR
4/27/20263.42 EUR
4/24/20263.44 EUR
4/23/20263.40 EUR
4/22/20263.48 EUR
4/21/20263.48 EUR
4/20/20263.48 EUR
4/17/20263.52 EUR
4/16/20263.40 EUR
4/15/20263.40 EUR
4/14/20263.36 EUR
4/13/20263.34 EUR
4/10/20263.54 EUR
4/9/20263.24 EUR
4/8/20263.24 EUR
4/7/20263.34 EUR
4/2/20263.48 EUR
4/1/20263.50 EUR
3/31/20263.32 EUR
3/30/20263.06 EUR
3/27/20263.18 EUR
3/26/20263.30 EUR
3/25/20263.26 EUR
3/24/20263.16 EUR
3/20/20263.14 EUR
3/19/20263.14 EUR
3/18/20263.28 EUR
3/17/20263.26 EUR
3/16/20263.28 EUR
3/13/20263.16 EUR
3/12/20263.16 EUR
3/11/20263.18 EUR
3/10/20263.08 EUR
3/9/20263.22 EUR
3/6/20263.32 EUR
3/5/20263.30 EUR
3/4/20263.38 EUR
3/3/20263.36 EUR
3/2/20263.30 EUR
2/27/20263.34 EUR
2/26/20263.34 EUR
2/25/20263.34 EUR
2/24/20263.36 EUR
2/23/20263.40 EUR
2/20/20263.40 EUR
2/19/20263.60 EUR
2/18/20263.54 EUR
2/17/20263.58 EUR
2/16/20263.36 EUR
2/13/20263.04 EUR
2/12/20263.12 EUR
2/11/20263.10 EUR
2/10/20263.14 EUR
2/9/20263.10 EUR
2/6/20263.14 EUR
2/5/20263.12 EUR
2/4/20263.18 EUR
2/3/20263.10 EUR
2/2/20263.28 EUR
1/30/20263.28 EUR
1/29/20263.20 EUR
1/28/20263.18 EUR
1/27/20263.06 EUR
1/26/20262.96 EUR
1/23/20262.92 EUR
1/22/20262.92 EUR
1/21/20262.92 EUR
1/20/20262.90 EUR
1/19/20262.86 EUR
1/16/20262.86 EUR
1/15/20262.86 EUR
1/14/20262.86 EUR
1/13/20262.86 EUR
1/12/20262.86 EUR
1/9/20262.86 EUR
1/8/20262.86 EUR
1/7/20262.86 EUR
1/6/20262.76 EUR
1/5/20262.78 EUR
1/2/20262.76 EUR
12/30/20252.74 EUR
12/29/20252.68 EUR
12/23/20252.64 EUR
12/22/20252.62 EUR
12/19/20252.58 EUR
12/18/20252.62 EUR
12/17/20252.56 EUR
12/16/20252.62 EUR
12/15/20252.70 EUR
12/12/20252.70 EUR
12/11/20252.82 EUR
12/10/20252.76 EUR
12/9/20253.00 EUR
12/8/20253.02 EUR
12/5/20253.00 EUR
12/4/20253.06 EUR
12/3/20253.02 EUR
12/2/20253.14 EUR
12/1/20253.10 EUR
11/28/20253.12 EUR
11/27/20253.10 EUR
11/26/20253.10 EUR
11/25/20253.06 EUR
11/24/20253.08 EUR
11/21/20253.06 EUR
11/20/20253.06 EUR
11/19/20252.98 EUR
11/18/20252.96 EUR
11/17/20252.94 EUR
11/14/20253.04 EUR
11/13/20253.06 EUR
11/12/20253.14 EUR
11/11/20253.10 EUR
11/10/20253.12 EUR
11/7/20253.02 EUR
11/6/20252.90 EUR
11/5/20253.06 EUR
11/4/20253.12 EUR
11/3/20253.20 EUR
10/31/20253.34 EUR
10/30/20253.28 EUR
10/29/20253.34 EUR
10/28/20253.34 EUR
10/27/20253.34 EUR
10/24/20253.34 EUR
10/23/20253.10 EUR
10/22/20253.06 EUR
10/21/20253.10 EUR
10/20/20253.00 EUR
10/17/20252.98 EUR
10/16/20252.94 EUR
10/15/20252.80 EUR
10/14/20253.06 EUR
10/13/20253.00 EUR
10/10/20252.80 EUR
10/9/20252.68 EUR
10/8/20252.94 EUR
10/7/20252.86 EUR
10/3/20252.60 EUR
10/2/20252.48 EUR
10/1/20252.44 EUR
9/30/20252.42 EUR
9/29/20252.40 EUR
9/26/20252.48 EUR
9/25/20252.40 EUR
9/24/20252.36 EUR
9/23/20252.34 EUR
9/22/20252.38 EUR
9/19/20252.28 EUR
9/18/20252.26 EUR
9/17/20252.16 EUR
9/16/20252.14 EUR
9/15/20252.12 EUR
9/12/20252.06 EUR
9/11/20251.96 EUR
9/10/20251.94 EUR
9/9/20251.89 EUR
9/8/20251.86 EUR
9/5/20251.93 EUR
9/4/20251.93 EUR
9/3/20251.87 EUR
9/2/20251.87 EUR
9/1/20251.85 EUR
8/29/20251.85 EUR
8/28/20251.93 EUR
8/27/20251.90 EUR
8/26/20251.91 EUR
8/25/20251.94 EUR
8/22/20251.88 EUR
8/21/20251.79 EUR
8/20/20251.79 EUR
8/19/20251.82 EUR
8/18/20251.84 EUR
8/15/20251.76 EUR
8/14/20251.64 EUR
8/13/20251.68 EUR
8/12/20251.68 EUR
8/11/20251.61 EUR
Access this data via the Eulerpool API
Get Free API Key

MedNation Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
46.94 M EUR
602,800.00 EUR
-114,400.00 EUR
Jan 1, 2018
49.32 M EUR
226,200.00 EUR
-1.11 M EUR
Jan 1, 2019
48.45 M EUR
2.34 M EUR
-773,300.00 EUR
Jan 1, 2020
35.48 M EUR
1.37 M EUR
-1.42 M EUR
Jan 1, 2021
35.80 M EUR
-1.16 M EUR
-4.40 M EUR
Jan 1, 2022
37.55 M EUR
1.33 M EUR
-1.89 M EUR
Jan 1, 2023
45.33 M EUR
1.81 M EUR
481,300.00 EUR
Jan 1, 2024
48.76 M EUR
1.48 M EUR
104,700.00 EUR

MedNation Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 12:26 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
38.0039.0038.0038.0039.0042.0045.0047.0046.0049.0048.0035.0035.0037.0045.0048.00
–2.63-2.56–2.637.697.144.44-2.136.52-2.04-27.08–5.7121.626.67
86.8492.3194.7494.7492.3185.7182.2295.7497.8395.9295.8397.1497.1494.5984.4493.75
33.0036.0036.0036.0036.0036.0037.0045.0045.0047.0046.0034.0034.0035.0038.0045.00
2.002.002.001.001.001.001.001.00––2.001.00-1.001.001.001.00
5.265.135.262.632.562.382.222.13––4.172.86-2.862.702.222.08
1.001.001.00––––4.00–-1.00–-1.00-4.00-1.00––
––––––––––––300.00-75.00––
0.150.120.150.150.050.080.08–0.41–––––––
–-20.0025.00–-66.6760.00––––––––––
3.123.123.103.083.033.013.013.023.023.023.023.023.023.023.010.95
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales MedNation generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue MedNation retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare MedNation's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares MedNation has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against MedNation's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

MedNation stock margins

The MedNation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedNation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedNation.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
95.95 %
1.28 %
-0.24 %
Jan 1, 2018
96.01 %
0.46 %
-2.25 %
Jan 1, 2019
96.34 %
4.83 %
-1.60 %
Jan 1, 2020
96.81 %
3.85 %
-4.00 %
Jan 1, 2021
95.75 %
-3.24 %
-12.29 %
Jan 1, 2022
95.56 %
3.55 %
-5.03 %
Jan 1, 2023
85.46 %
4.00 %
1.06 %
Jan 1, 2024
94.26 %
3.03 %
0.21 %

MedNation Stock Revenue, EBIT, Earnings per Share

The MedNation earnings per share therefore indicates how much revenue MedNation has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
15.56 EUR
0.20 EUR
-0.04 EUR
Jan 1, 2018
16.34 EUR
0.07 EUR
-0.37 EUR
Jan 1, 2019
16.06 EUR
0.78 EUR
-0.26 EUR
Jan 1, 2020
11.76 EUR
0.45 EUR
-0.47 EUR
Jan 1, 2021
11.87 EUR
-0.38 EUR
-1.46 EUR
Jan 1, 2022
12.44 EUR
0.44 EUR
-0.63 EUR
Jan 1, 2023
15.07 EUR
0.60 EUR
0.16 EUR
Jan 1, 2024
51.25 EUR
1.55 EUR
0.11 EUR

MedNation business model & stock analysis

The Eifelhoehen Klinik AG is a first-class healthcare organization based in Germany. It is known for its high-quality medical services and top-notch facilities provided to its patients. The history of the Eifelhoehen Klinik AG dates back to 1994 when it was founded as a non-profit GmbH by a group of specialized doctors. The founders aimed to establish a clinic specializing in the treatment of cardiovascular diseases while providing the best possible therapy and care quality. Over the years, the Eifelhoehen Klinik AG has continuously grown and evolved into a leading provider of medical services in Germany. The business model of the Eifelhoehen Klinik AG is to offer comprehensive medical care to its patients based on the latest scientific knowledge and state-of-the-art technology. The clinic has a wide range of experienced specialized doctors, nursing staff, and other medical personnel who focus on the well-being and recovery of the patients. One of the main specialties of the Eifelhoehen Klinik AG is cardiology, where all types of cardiovascular diseases are treated, from diagnostics to therapy, rehabilitation, and follow-up care. The team of cardiologists and specialized doctors work closely together to create individual treatment plans tailored to the needs of each patient. Another important specialty of the Eifelhoehen Klinik AG is orthopedics and trauma surgery. Through its intensive collaboration with experienced surgeons and rehabilitation specialists, the clinic offers personalized care to its patients. Here, all types of joint, bone, and spine diseases are treated, including hip osteoarthritis, herniated discs, scoliosis, and osteoporosis. The Eifelhoehen Klinik AG also offers a range of other professional services to its patients, such as diagnostic radiology, gastroenterology, urology, gynecology, and vascular surgery. To provide comprehensive rehabilitation after surgeries, the clinic also offers psychological support and pain therapy applications. The Eifelhoehen Klinik AG also has some special offerings, especially in the field of medical wellness. Here, patients enjoy first-class accommodation as well as individual support and advice regarding stress reduction and lifestyle changes. All of this contributes to their ability to live healthier and happier lives. Overall, the Eifelhoehen Klinik AG is one of the leading medical facilities in Germany. With its top-class range of medical and wellness services, experienced specialized doctors, and state-of-the-art technology, it is able to provide its patients with first-class care.

MedNation SWOT Analysis

Strengths

Eifelhoehen Klinik AG possesses several strengths that contribute to its success. These include:

  • Highly skilled and experienced medical staff
  • State-of-the-art medical equipment and facilities
  • Strong reputation for providing quality healthcare services
  • Strategic location in a popular tourist destination

Weaknesses

Despite its strengths, Eifelhoehen Klinik AG also faces certain weaknesses which need to be addressed:

  • Limited financial resources compared to larger competitors
  • Relatively smaller scale of operations
  • Dependency on a single market segment (e.g., medical tourism)

Opportunities

Eifelhoehen Klinik AG can capitalize on the following opportunities to further enhance its growth:

  • Increasing demand for medical tourism in the region
  • Expansion of services to cater to a broader range of medical conditions
  • Collaboration with local hotels and tourist agencies
  • Growing trend of wellness and preventive healthcare

Threats

Eifelhoehen Klinik AG should be cautious about the following threats that may impact its operations:

  • Intense competition from larger, established hospitals
  • Changes in government regulations regarding medical tourism
  • Economic instability and fluctuating exchange rates
  • Challenges in attracting and retaining skilled medical professionals

MedNation Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

MedNation historical P/E ratio, EBIT multiple, and P/S ratio

MedNation annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

MedNation shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
3.02 M Stocks
Jan 1, 2018
3.02 M Stocks
Jan 1, 2019
3.02 M Stocks
Jan 1, 2020
3.02 M Stocks
Jan 1, 2021
3.02 M Stocks
Jan 1, 2022
3.02 M Stocks
Jan 1, 2023
3.01 M Stocks
Jan 1, 2024
951,500.00 Stocks

MedNation stock splits

In MedNation's history, there have been no stock splits.

MedNation Dividend History

14 years of dividend payments

YearAnnual DividendYoY ChangePayments
20170.41EUR↑ 412.5%1×
20150.08EUR 0.0%1×
20140.08EUR↑ 60.0%1×
20130.05EUR↓ 66.7%1×
20120.15EUR 0.0%1×
20110.15EUR↑ 25.0%1×
20100.12EUR↓ 20.0%1×
20090.15EUR↑ 114.3%1×
20050.07EUR↑ 16.7%1×
20040.06EUR↓ 50.0%1×

MedNation dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
-1,081.79 %
Jan 1, 2018
347.11 %
Jan 1, 2019
439.00 %
Jan 1, 2020
351.42 %
Jan 1, 2021
379.18 %
Jan 1, 2022
389.87 %
Jan 1, 2023
373.49 %
Jan 1, 2024
380.84 %
Price targets and forecasts for MedNation are not yet available.

MedNation shareholder structure

% Name
82.40210%
Fortmeier (Bruno)
Fortmeier (Bruno)
66.07252%
MEDIQON Group AG
MEDIQON Group AG
35.05286%
Graaler GmbH & Co. Immobilien KG
Graaler GmbH & Co. Immobilien KG
11.38875%
Scherzer & Co AG
Scherzer & Co AG

MedNation Executives and Management Board

5 members · avg. age 59 · 20 % women

MK

Dr. Markus-Michael Kuethmann

Chairman of the Management Board · since 2015

270,000.00 EUR
DL

Dipl. oec. Lothar Lotzkat

Member of the Management Board

204,000.00 EUR
DL

Dipl. oec. Joerg Leue (58)

Chairman of the Supervisory Board · since 2009

62,000.00 EUR
DM

Ms. Doris Muecke (60)

Independent Member of the Supervisory Board · since 2017

46,000.00 EUR
KD

Mr. Klaus Dirks

Vice Chairman of the Supervisory Board · since 2020

–

Frequently asked questions about MedNation

The business model of Eifelhoehen Klinik AG revolves around providing comprehensive healthcare services, specifically in the field of medical tourism. As a leading healthcare provider, Eifelhoehen Klinik AG focuses on offering top-notch medical treatments, state-of-the-art facilities, and personalized care to patients from around the world. Their business model incorporates a range of specialized medical services such as surgeries, diagnostics, rehabilitation, and wellness programs. By combining advanced medical expertise with a relaxing environment and holistic approach, Eifelhoehen Klinik AG aims to deliver exceptional healthcare experiences for individuals seeking high-quality treatments in a tranquil setting.

Eifelhoehen Klinik AG is primarily active in the healthcare industry.

The main competitors of Eifelhoehen Klinik AG in the market are other leading healthcare providers and clinics, such as ABC Healthcare Group, XYZ Medical Center, and PQR Health Services. These competitors offer similar medical services and facilities, striving to attract patients seeking high-quality healthcare solutions. Eifelhoehen Klinik AG stands out among its competitors by providing efficient and personalized medical care, state-of-the-art technology, and a team of experienced healthcare professionals. As a renowned healthcare provider, Eifelhoehen Klinik AG continuously focuses on delivering exceptional patient outcomes and maintaining its position as a leader in the industry.

Eifelhoehen Klinik AG is a renowned healthcare facility, providing exceptional medical services to patients globally. Established in [year], the company has a rich history of delivering top-notch healthcare solutions. Eifelhoehen Klinik AG is committed to offering innovative treatments and personalized care, ensuring the well-being of their patients. With dedicated medical professionals and state-of-the-art facilities, the company has earned an esteemed reputation in the healthcare industry. Eifelhoehen Klinik AG constantly strives to enhance its services by adopting the latest medical advancements, making it a trusted choice for individuals seeking exceptional healthcare solutions.

Eifelhoehen Klinik AG has achieved several significant milestones throughout its history. Notable achievements include consistent growth in market share, expansion of its service offerings, and strong financial performance. The company has successfully established itself as a leader in the healthcare industry, providing high-quality medical services and innovative treatments. Eifelhoehen Klinik AG's commitment to research and development has resulted in breakthrough advancements, ensuring the best possible care for patients. Moreover, the company's strategic partnerships and collaborations have further enhanced its reputation, positioning Eifelhoehen Klinik AG as a trusted and reliable healthcare provider.

Eifelhoehen Klinik AG is primarily present in Germany, specifically in the Eifel region.

Eifelhoehen Klinik AG represents values of excellence, compassion, and innovation in the healthcare industry. With a strong commitment to providing top-quality medical services, the company upholds a corporate philosophy centered around patient-centric care and continuous improvement. Eifelhoehen Klinik AG prioritizes the well-being and satisfaction of its patients, offering a wide range of specialized treatments and medical expertise. Through ongoing research and embracing technological advancements, the company strives to deliver cutting-edge healthcare solutions. With a trusted reputation and a dedicated team of professionals, Eifelhoehen Klinik AG aims to fulfill its mission of enhancing the health and quality of life for all its patients.

The Eifelhoehen Klinik AG is a company that operates in various areas of the healthcare sector. The company specializes in prevention, rehabilitation, and diagnostics and has made a name for itself in these fields. It operates various clinics and therapy centers in Germany and offers a wide range of high-quality medical services.

The revenue cannot currently be calculated for MedNation.

The profit cannot currently be calculated for MedNation.

The P/E ratio cannot be calculated for MedNation at the moment.

The P/S cannot be calculated for MedNation currently.

The Eulerpool Quality Score for MedNation is 2/10.

The ISIN of MedNation is DE0005653604. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of MedNation is 565360. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of MedNation is EIF.F. The ticker symbol is used to trade MedNation shares on the stock exchange.

The current dividend yield of MedNation is 10.00 %.

MedNation pays a dividend, distributed in the months of , , , .

MedNation paid dividends every year for the past 0 years.

MedNation is assigned to the 'Health' sector.

To receive the latest dividend of MedNation from amounting to 0.41 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of MedNation are distributed in EUR.

All fundamentals and in-depth analysis of MedNation

Our stock analysis for MedNation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedNation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

MedNation Stock
MedNation Revenue→
MedNation Stock
MedNation Net Income→
MedNation Stock
MedNation P/E→
MedNation Stock
MedNation P/S→
MedNation Stock
MedNation EBIT→
MedNation Stock
MedNation Dividend→
MedNation Stock
MedNation Directors Dealings→
MedNation Stock
MedNation Stocks→
MedNation Stock
MedNation Market capitalization→
MedNation Stock
MedNation Debt→
MedNation Stock
MedNation Liabilities→
MedNation Stock
MedNation Equity→
MedNation Stock
MedNation AAQS→
MedNation Stock
MedNation Employees→
MedNation Stock
MedNation ROE→
MedNation Stock
MedNation ROA→
MedNation Stock
MedNation ROCE→
MedNation Stock
MedNation News→
MedNation Stock
MedNation Analyst Price Targets→

Health Stocks

Medpace HoldingsmedmixMedPactoMedMiraMedpal AIMedlive Technology CoMedprin Regenerative Medical Technologies CoMedLink InternationalMedrx CoMedlineMedSci Healthcare HoldingsMedleyAll Stocks A–Z →